The Irreversible March of Time: Ischemic Delay and Impact on Outcomes in ST-Segment Elevation Myocardial Infarction
Artur Dziewierz1,2, Barbara Zdzierak1,2, Wojciech Wańha3
12nd Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Insights
Time is Muscle in ST-elevation myocardial infarction (STEMI) care. Reducing delays in treatment is crucial, as every minute of ischemia increases heart damage, mortality, and heart failure risk.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- ST-segment elevation myocardial infarction (STEMI) is a medical emergency caused by blocked coronary arteries.
- Myocardial necrosis progresses with ischemic duration, directly impacting infarct size and patient outcomes.
Purpose of the Study:
- To analyze components of total ischemic time in STEMI.
- To quantify clinical consequences of treatment delays.
- To evaluate evidence-based strategies for mitigating delays.
Main Methods:
- Review of literature on STEMI treatment timelines.
- Analysis of patient- and system-related delays.
- Evaluation of interventions from fibrinolysis to primary percutaneous coronary intervention (PCI).
Main Results:
- Total ischemic time significantly influences STEMI outcomes.
- System-level interventions have reduced treatment times.
- Disparities in care persist based on various demographic and geographic factors.
Conclusions:
- Reducing ischemic time is paramount in STEMI management.
- Targeted interventions and emerging technologies like AI can further improve outcomes.
- Addressing persistent disparities is essential for equitable STEMI care.
Abstract:
ST-segment elevation myocardial infarction (STEMI) represents a time-critical medical emergency where complete coronary artery occlusion initiates progressive myocardial necrosis. The fundamental principle of modern STEMI care-"Time is Muscle"-establishes that ischemic duration directly determines infarct size and clinical outcomes. Each minute of delay correlates with increased mortality, larger infarcts, and a higher risk of heart failure development. Total ischemic time encompasses both patient-mediated delays (often the largest component) and system-related delays, each influenced by distinct factors requiring targeted interventions. This comprehensive review analyzes the components of total ischemic time, quantifies the clinical consequences of delay, and evaluates evidence-based mitigation strategies. We examine the evolution from fibrinolysis to primary percutaneous coronary intervention and the resulting logistical challenges. System-level interventions-including public awareness campaigns, regionalized STEMI networks, pre-hospital ECG acquisition, and standardized hospital protocols-have dramatically reduced treatment times. However, persistent disparities based on geography, presentation timing, sex, race, and age remain problematic. Emerging technologies, particularly artificial intelligence for ECG interpretation, offer promise for further time reduction.
More Related Videos
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
